Most Profitable Life Sciences Tools & Services Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
6.34 B
(0.03)
 1.55 
(0.05)
2IQV IQVIA Holdings
1.37 B
(0.10)
 1.59 
(0.16)
3A Agilent Technologies
1.29 B
(0.13)
 1.62 
(0.21)
4MTD Mettler Toledo International
863.14 M
(0.03)
 1.59 
(0.05)
5ICLR ICON PLC
791.47 M
(0.11)
 2.05 
(0.23)
6AVTR Avantor
711.5 M
(0.14)
 2.73 
(0.39)
7WAT Waters
637.83 M
(0.01)
 1.83 
(0.02)
8MEDP Medpace Holdings
404.39 M
(0.04)
 1.97 
(0.09)
9RVTY Revvity
270.38 M
(0.03)
 1.99 
(0.06)
10CDT Conduit Pharmaceuticals
198.41 M
(0.14)
 16.53 
(2.27)
11TECH Bio Techne Corp
168.07 M
(0.14)
 2.16 
(0.31)
12BRKR Bruker
113.8 M
(0.19)
 2.57 
(0.50)
13QGEN Qiagen NV
83.59 M
(0.12)
 1.50 
(0.18)
14SHC Sotera Health Co
44.4 M
(0.08)
 2.18 
(0.18)
15CRL Charles River Laboratories
25.29 M
(0.10)
 2.33 
(0.24)
16AFJK Aimei Health Technology
2.55 M
 0.13 
 0.43 
 0.06 
17CSBR Champions Oncology
(7.28 M)
 0.04 
 5.44 
 0.23 
18HBIO Harvard Bioscience
(12.4 M)
(0.42)
 4.36 
(1.82)
19CGEN Compugen
(14.23 M)
 0.03 
 4.76 
 0.14 
20CTOR Citius Oncology,
(21.15 M)
(0.08)
 7.28 
(0.56)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.